跳到主要內容區塊
:::首頁 > 就醫指南 > 醫師專長介紹

蔡易臻醫師

引用
現在日期 2024/04/19
科別分類符號 醫師個人簡介
主治專長
乳房外科、乳房疾病、乳房腫瘤手術、乳癌相關診斷及治療
專業經驗
臺中榮民總醫院 乳房腫瘤外科
重要經歷/進修訓練
現任:臺中榮民總醫院外科部 乳房腫瘤外科主治醫師
臺北榮民總醫院外科部一般外科住院醫師
臺北榮民總醫院外科部一般外科總醫師
高雄榮民總醫院屏東分院外科部主治醫師
學歷
國立臺灣大學醫學系畢業
現讀 中國醫藥大學生物醫學研究所博士班
專科證照
衛生署醫師執照
衛生署外科專科醫師
台灣消化系外科醫學會專科醫師
台灣內視鏡外科專科醫師
台灣乳房專科醫師
代表作
1. Efficacy Of Pegylated Liposomal Doxorubicin-based Neoadjuvant Chemotherapy In Breast Cancer: A Single Center Experience.
Tsai IC, Hung CC.
Clin Invest Med. 2021 Mar 21;44(1):E7-14.
2. Preliminary outcomes of accelerated partial breast irradiation by interstitial multicatheter brachytherapy with intraoperative free-hand catheter implantation in early breast cancer.
Cheng HS, Hung CC, Wang KC, Tsai IC, Lin JF, Yeh HL.
J Chin Med Assoc. 2023 Feb 28:e000893. doi: 10.1097/JCMA.0000000000000893. Online ahead of print.
3. Comparison of overall survival after neoadjuvant and adjuvant chemotherapy in patients with early breast cancer with immediate breast reconstruction after mastectomy: A retrospective, matched case-control study.
Liu CH, Yang JR, Tsai IC, Hsu CY, Yean LC, Hung CC.
Oncol Lett. 2022 Oct 21;24(6):437. doi: 10.3892/ol.2022.13557. eCollection 2022 Dec.
4. Analysis of EZH2 Genetic Variants on Triple-Negative Breast Cancer Susceptibility and Pathology.
Liu LC, Chien YC, Wu GW, Hua CH, Tsai IC, Hung CC, Wu TK, Pan YR, Yang SF, Yu YL.
Int J Med Sci. 2022 May 29;19(6):1023-1028. doi: 10.7150/ijms.71931. eCollection 2022.
5. Clinical Outcomes of Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2 Breast Cancer Patients: A Single-Center Retrospective Study.
Hung CC, Tsai IC, Hsu CY, Lin HC.
J Clin Med. 2022 Mar 5;11(5):1434. doi: 10.3390/jcm11051434.
6. Capsanthin induces G1/S phase arrest, erlotinib-sensitivity and inhibits tumor progression by suppressing EZH2-mediated epigenetically silencing of p21 in triple-negative breast cancer cells.
Wu JY, Chien YC, Tsai IC, Hung CC, Huang WC, Liu LC, Yu YL.
Aging (Albany NY). 2021 May 2;13(9):12514-12525. doi: 10.18632/aging.202925. Epub 2021 May 2.
7. The Efficacy of Pegylated Liposomal Doxorubicin-Based Neoadjuvant Chemotherapy in Breast Cancer: A Retrospective Case-Control Study in Taiwan.
Hung CC, Yang Y, Tsai IC, Hsu CY, Liu CH, Yang JR.
Biochem Res Int. 2020 Apr 28;2020:5729389. doi: 10.1155/2020/5729389. eCollection 2020.
8. Breast adenosquamous cell carcinoma presented in an intracystic form.
Liu Y, Hung CC, Chen YA, Tsai IC.
Asian J Surg. 2019 Jun;42(6):711-714. doi: 10.1016/j.asjsur.2019.02.005. Epub 2019 Mar 11.
回頂端